Description

Favipiravir Film-Coated Tablets (200 mg / 400 mg / 800 mg)

Healthy Inc is a specialized global supplier and exporter of advanced antivirals, infectious disease, and rapid outbreak-response therapeutics. We provide ultra-high-purity, kinetically stabilized Favipiravir Film-Coated Tablets (200 mg / 400 mg / 800 mg), manufactured in WHO–GMP certified, high-capacity, strictly moisture-controlled oral solid dosage facilities. This “Broad-Spectrum RNA Polymerase Inhibitor” is a massive-volume, highly strategic export to national pandemic stockpiles, tropical medicine NGOs, infectious disease networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated reserve intervention for novel or resistant Influenza strains and emerging RNA viral outbreaks.

Product Overview

This highly advanced formulation operates as a devastating “Trojan Horse” against RNA viruses. Unlike traditional antivirals that merely try to stop a virus from entering or exiting a cell, Favipiravir infiltrates the viral replication machinery itself, forcing the virus to mutate so rapidly that it essentially self-destructs.

The “RdRp Inhibitor & Lethal Mutagenesis” Specialist:

• Mechanism 1 (The Intracellular Activation): Favipiravir is a prodrug. Once it enters an infected human cell, cellular enzymes rapidly convert it into its active form: Favipiravir-RTP (ribofuranosyl-5′-triphosphate). This active metabolite is structurally disguised to look exactly like the natural purine nucleotides (guanosine and adenosine) the virus needs to build its genetic code.
• Mechanism 2 (The RNA Polymerase Blockade): RNA viruses use an enzyme called RNA-dependent RNA polymerase (RdRp) to copy their genome and multiply. When the viral RdRp attempts to build a new RNA strand, it mistakenly grabs the Favipiravir-RTP molecule instead of a natural nucleotide. Once incorporated, it physically blocks the polymerase from continuing the chain, instantly halting viral replication.
• Mechanism 3 (Lethal Mutagenesis): In addition to chain termination, Favipiravir forces widespread, catastrophic copying errors into the viral RNA. The virus replicates with so many genetic mutations that the resulting viral particles are completely non-infectious and biologically dead. This unique mechanism makes it incredibly difficult for viruses to develop resistance to the drug.

Product Composition & Strength

We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.

*Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Infectious Disease Distributors, and Government Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Pandemic Surge Capacity & Teratogenic Handling (CRITICAL COMPLIANCE): Manufacturing Favipiravir requires the ability to scale production instantly during a national viral outbreak. Our high-speed rotary presses can generate millions of units rapidly to fulfill emergency government tenders. Furthermore, because Favipiravir is highly teratogenic, our facilities utilize dedicated air-handling units and strict heavy film-coating protocols to ensure factory workers and dispensing pharmacists are absolutely shielded from airborne API dust.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly specialized management of severe, novel, or emerging RNA viral infections:

• Novel & Drug-Resistant Influenza: Treatment of novel or re-emerging pandemic influenza virus infections (where other antivirals like Oseltamivir are ineffective or contraindicated).
• Emerging RNA Viruses (Off-Label / Outbreak Protocols): Frequently deployed by NGOs and health ministries under emergency use protocols for outbreaks of Ebola, Lassa fever, Nipah virus, and severe acute respiratory coronaviruses.

Dosage & Administration

Recommended Dosage (Strictly as per Infectious Disease Guidelines):

• The Loading Dose Protocol: Favipiravir requires a massive initial loading dose to reach therapeutic blood levels rapidly. A standard protocol is 1600 mg to 1800 mg taken twice daily on Day 1, followed by a maintenance dose of 600 mg to 800 mg twice daily for 4 to 13 subsequent days.
• Administration: Can be taken with or without food. Tablets should be swallowed whole.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX EQUIVALENT (Severe Teratogenicity & Embryotoxicity): FATAL WARNING: Favipiravir causes catastrophic birth defects and early fetal death. It is absolutely contraindicated in women who are or may become pregnant. A negative pregnancy test is strictly required before initiation.
• Semen Transmission Warning: The drug is actively secreted in semen. Male patients must use highly effective barrier contraception (condoms) during treatment and for at least 7 days after the final dose to prevent exposing a female partner to the teratogenic compound.
• Hyperuricemia & Gout: Favipiravir significantly decreases the excretion of uric acid. Patients frequently experience severe spikes in blood uric acid levels, which can trigger agonizing attacks of acute gout or uric acid kidney stones.
• Hepatic Impairment: Because it is heavily metabolized by the liver (aldehyde oxidase), patients with severe hepatic impairment require extreme caution and strict dose modifications to prevent toxic accumulation.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and NGO Outbreak Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antivirals, RNA Polymerase Inhibitors, and Macrodose Tableting Formulations. Whether you are looking for a reliable Government Tender Supplier for national pandemic stockpiles in Africa or a B2B Pharma Marketplace partner for Southeast Asia, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.